FDA approves Teva's generic of Mylan's EpiPen

The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's life-saving allergy injection, EpiPen, at a time when regulators are looking to lower healthcare costs.



from Reuters: Health News https://reut.rs/2MRsV6K
http://bit.ly/2zwRqiM